The emergence of artificial intelligence (AI) in healthcare is the result of increased demand for tailored healthcare solutions, lower costs, higher accuracy pertaining to medical decisions and diagnosis to improve patient health outcomes.
With an estimated valuation of $15.1 billion for the global market in 2022, AI in healthcare is an irreversible process that is already reshaping medicine and...
Google announced the release of MedLM, two foundational models built off Med-PaLM 2, designed to answer medical questions, generate insights from unstructured data and summarize medical information.
The tech giant said that through piloting its LLMs with healthcare organizations, it has learned the most effective AI models are designed to address specific use cases. Therefore, the large model...
Leaders in the digital health space told MobiHealthNews their predictions about where AI will make the most significant mark in healthcare in 2024.
Following the considerable increase in the use of AI in healthcare in 2023, stakeholders expect next year to bring even wider adoption of the technology across various sectors, from implementation in physician-facing tools that help ease provider...
Digital metabolic care startup Twin Health announced it has raised $50 million in funding, two years after securing $140 million in Series C funding.
Temasek led the funding with participation from existing investors Sofina, ICONIQ Growth, Helena, and Peak XV.
WHAT IT DOES
Twin’s product is the Whole Body Digital Twin, an AI-backed model that aims to provide individualized nutrition, sleep and...
AI in healthcare and value-based care enablement are top developing trends in healthcare, but lack scalability so far, while big box retailers as providers and data interoperability have shown a high volume of activity in 2023, and are scaling with long-term trajectories.
Rock Health's report, which utilized data to determine the sequence of developments in the digital health space this year,...
A study done by Google Research in collaboration with Google DeepMind reveals the tech giant developed an LLM with conversational and collaborative capabilities that can provide an accurate differential diagnosis (DDx) and help improve clinicians' diagnostic reasoning and accuracy in diagnosing complex medical conditions.
The LLM for DDx builds upon Med-PaLM 2, the company's generative AI...
Leaders in the digital health space relayed to MobiHealthNews what stood out to them in 2023 as the year draws to an end.
Many noted the meteoric rise of genAI in 2023 and expectations of growing adoption of the technology in 2024, emphasizing the importance of treading carefully as the tech is further implemented. Other stakeholders pinpointed bankruptcies and mergers and acquisitions as being...
Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of novel cancer treatments with the help of genAI technology.
The project will leverage Absci's Integrated Drug Creation platform – which combines scalable wet lab technologies with AI, and facilitates...
Dr. Michael Howell, chief clinical officer at Google, sat down with MobiHealthNews to discuss noteworthy events in 2023, the evolution of the company's LLM for healthcare, called Med-PaLM, and recommendations for regulators in constructing rules around the use of artificial intelligence in the sector.
MobiHealthNews: What are some of your big takeaways from 2023?
Dr. Michael Howell: For us,...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
